University of Delaware Drops Patent Lawsuit against Phenomenex | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Separations science firm Phenomenex today said that the University of Delaware has dropped its lawsuit against the firm claiming patent infringement.

The case was officially dismissed on Feb. 2, Phenomenex said in a statement, adding that it came after the university informed the company that it would withdraw the case if Phenomenex would not countersue the school for legal fees.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.